Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Dongdong Wang, Yang Yang, Yingnan Lei, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 4, pp. 596-670
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Dongdong Wang, Emily A. Day, Logan K. Townsend, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 10, pp. 592-607
Closed Access | Times Cited: 312
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 243
Naringenin and naringin in cardiovascular disease prevention: A preclinical review
Reza Heidary Moghaddam, Zeinab Samimi, Seyed Zachariah Moradi, et al.
European Journal of Pharmacology (2020) Vol. 887, pp. 173535-173535
Closed Access | Times Cited: 175
Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
Hui Jiang, Yongwen Zhou, Seyed Mohammad Nabavi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 141
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review
Fan-shun Zhang, Qing-ze He, Cheng Xue Qin, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 9, pp. 2173-2190
Open Access | Times Cited: 87
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases
Qian Lu, Yanli Zhu, Chao Deng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Inflammatory Cells in Atherosclerosis
Marcelle Mehu, Chandrakala Aluganti Narasimhulu, Dinender K. Singla
Antioxidants (2022) Vol. 11, Iss. 2, pp. 233-233
Open Access | Times Cited: 70
TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis
Xiaoqing Guo, Bowei Li, Cheng Wen, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 5
Closed Access | Times Cited: 45
Mechanisms of wogonoside in the treatment of atherosclerosis based on network pharmacology, molecular docking, and experimental validation
Zhaohui Gong, Haixin Yang, Li Gao, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics
Zhenghong Liu, Xiaoxuan Ma, Iqra Ilyas, et al.
Theranostics (2021) Vol. 11, Iss. 9, pp. 4502-4515
Open Access | Times Cited: 99
Metformin, Macrophage Dysfunction and Atherosclerosis
Xiaojun Feng, Wenxu Chen, Xiayun Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93
Chlorogenic Acids in Cardiovascular Disease: A Review of Dietary Consumption, Pharmacology, and Pharmacokinetics
Lin Li, Congping Su, Xiang‐Yang Chen, et al.
Journal of Agricultural and Food Chemistry (2020) Vol. 68, Iss. 24, pp. 6464-6484
Closed Access | Times Cited: 90
CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications
Kunming Tian, Yan Xu, Amirhossein Sahebkar, et al.
Current Atherosclerosis Reports (2020) Vol. 22, Iss. 10
Closed Access | Times Cited: 83
Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes
Chang Shang, Hongchen Lin, Xuqin Fang, et al.
Food & Function (2021) Vol. 12, Iss. 24, pp. 12194-12220
Open Access | Times Cited: 74
Relationship between lipoproteins, thrombosis, and atrial fibrillation
Wern Yew Ding, Majd Protty, Ian G. Davies, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 3, pp. 716-731
Open Access | Times Cited: 73
Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function
Yu Ding, Yongwen Zhou, Ping Ling, et al.
Theranostics (2021) Vol. 11, Iss. 19, pp. 9376-9396
Open Access | Times Cited: 66
Yin-xing-tong-mai decoction attenuates atherosclerosis via activating PPARγ-LXRα-ABCA1/ABCG1 pathway
Shasha Zheng, Hong Huang, Yizhuo Li, et al.
Pharmacological Research (2021) Vol. 169, pp. 105639-105639
Closed Access | Times Cited: 57
Kaempferol and atherosclerosis: From mechanism to medicine
Meijie Chen, Jianbo Xiao, Hesham R. El‐Seedi, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 8, pp. 2157-2175
Closed Access | Times Cited: 48
The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis
Rajeev K. Singla, Ronita De, Thomas Efferth, et al.
Phytomedicine (2022) Vol. 108, pp. 154520-154520
Open Access | Times Cited: 45
Ferroptosis: A Potential Target in Cardiovascular Disease
Yanlong Leng, Xing Luo, Jiaying Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 42
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8162-8162
Open Access | Times Cited: 25
MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice
Jia Shi, Ming Ming Yang, Shu Yang, et al.
Phytomedicine (2024) Vol. 128, pp. 155489-155489
Closed Access | Times Cited: 12
Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment
Yu Jiang, Miao Yu, Zhifeng Song, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2553-2571
Open Access | Times Cited: 9
Curcumin Equipped Nanozyme‐Like Metal−Organic Framework Platform for the Targeted Atherosclerosis Treatment with Lipid Regulation and Enhanced Magnetic Resonance Imaging Capability
Fanzhen Lv, Huaqiang Fang, Li Huang, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 9
Cyclodextrins: Potential therapeutics against atherosclerosis
Maryam Mahjoubin‐Tehran, Petri T. Kovanen, Suowen Xu, et al.
Pharmacology & Therapeutics (2020) Vol. 214, pp. 107620-107620
Closed Access | Times Cited: 62
Page 1 - Next Page

Scroll to top